An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma
Clinical trial NCT03779113 · TERMINATED
Trial details
- NCT number
- NCT03779113
- Sponsor
- Hutchmed
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2025-02-26
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.